Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2016-12-15 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Exercise of Share Options
Share Issue/Capital Change Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content announces the 'Exercise of Share Options' and the subsequent application for admission to trading of new ordinary shares. This is a specific corporate action announcement related to capital structure/share issuance, but the primary nature of the filing itself is a general regulatory notification disseminated via the RNS system. Since the announcement details a change in the number of shares in issue following an option exercise, it strongly relates to 'Share Issue/Capital Change' (SHA). However, because it is explicitly formatted and distributed as an RNS announcement, and the core action is a notification of a change in share capital, SHA is the most specific fit among the primary definitions, although RNS is the distribution channel. Given the options, 'SHA' (Share Issue/Capital Change) describes the substance better than the general 'RNS' fallback, as it is a specific capital event notification. The document length is short (2273 chars), but it is the report/announcement itself, not an announcement *about* a report, so the RPA rule does not strictly apply here to downgrade it to RPA/RNS unless SHA was unavailable. SHA is available and fits the content (new shares admitted to trading).
2016-12-15 English
Exercise of Share Options
Share Issue/Capital Change Classification · 99% confidence The document is an RNS announcement dated December 12, 2016, from Alliance Pharma PLC. The core content announces the 'Exercise of Share Options' and the subsequent application for admission to trading of 480,496 new Ordinary Shares. This action directly relates to changes in the company's issued share capital due to employee option exercises. This fits the definition of 'Share Issue/Capital Change' (SHA). Although it is an RNS announcement, the specific subject matter (share issuance/capital change) is more precisely covered by SHA than the general fallback RNS code.
2016-12-12 English
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with "RNS Number : 4667R" and contains the standard structure for a TR-1 notification, which details changes in major shareholdings (insider/significant shareholder transactions). This type of filing reports personal share transactions by directors/executives or changes in significant ownership thresholds. The definition for 'Director's Dealing' (DIRS) covers personal share transactions by executives, and 'Major Shareholding Notification' (MRQ) covers changes in significant ownership levels. Since this is a TR-1 form detailing Aviva plc's change in holding crossing a threshold (9% to 8%), it directly relates to a Major Shareholding Notification (MRQ). Although it is distributed via RNS, MRQ is the more specific classification for the content type.
2016-12-09 English
Capital Markets Event
Report Publication Announcement Classification · 99% confidence The document is an RNS announcement (RNS Number : 2558R) dated December 8, 2016, titled "ALLIANCE PHARMA PLC ("Alliance" or the "Company") Capital Markets Event". It explicitly states that the company will host a 'capital markets event for equity analysts and institutional investors' which will include 'presentations on various aspects of Alliance's business from the wider management team.' This content aligns perfectly with the definition of an Investor Presentation (IP), which often takes the form of a capital markets day presentation. Although it is an announcement, the core subject matter is the presentation itself, making IP a stronger fit than RPA or RNS, as it details the content being presented to investors.
2016-12-08 English
Notification of Major Interest in Shares
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with "RNS Number : 6019Q" and concludes with "This information is provided by RNS The company news service from the London Stock Exchange". The content details a TR-1 notification regarding a change in major interest in shares (specifically, a 'CHANGE IN NATURE : RETURN OF LOANED SHARES') by Aviva plc, which involves crossing a voting rights threshold (8% to 9%). This type of mandatory disclosure concerning share ownership changes is a standard regulatory filing. Since there is a specific category for 'Director's Dealing' (DIRS) which covers insider trades, and this relates to a major shareholder's holding change, the most appropriate general regulatory filing category is RNS, as it covers mandatory disclosures that don't fit more specific categories like DIRS or DIV, although it is closely related to share ownership changes (MRQ). However, TR-1 forms are standard regulatory notifications disseminated via RNS. Given the options, RNS is the best fit for a general regulatory disclosure disseminated through the RNS system, although MRQ (Major Shareholding Notification) is also highly relevant. Since TR-1 is a specific form type often categorized broadly under regulatory announcements, RNS is chosen as the primary classification for this type of mandatory market disclosure.
2016-11-30 English
Exercise of Share Options
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content explicitly announces the 'Exercise of Share Options' leading to the issuance and admission to trading of new ordinary shares, and states the resulting total number of shares in issue. This action directly relates to a change in the company's capital structure (share issuance). While it is a regulatory announcement (RNS), the specific nature of announcing the issuance of new shares following option exercises aligns most closely with the 'Share Issue/Capital Change' definition (SHA). Since it is a formal announcement of a capital change, SHA is more specific than the general RNS fallback.
2016-11-23 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.